Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07032636 · ClinicalTrials.gov registry record · NA

Reducing Crises and Suicide Within the Idaho Army National Guard

A NA study, sponsored by University of Rochester.

Recruiting
Registry status
NA
Development phase
450
Enrollment target

NCT07032636 is a NA study that is actively recruiting participants, run by University of Rochester. The registered enrollment target is 450 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07032636, a NA study, is actively recruiting participants, sponsored by University of Rochester.

RECRUITING
Registry status
NA
Development phase
450 participants
Enrollment target

Study Summary

Military suicide is an ongoing public health concern, particularly within the Army National Guard (ARNG), with longstanding effects on fellow soldiers, family, and friends. The straddling of military and civilian worlds for ARNG can worsen risk factors for suicide, including increased social isolation, disruption to family life, and employment difficulties. One promising framework that addresses both unit cohesion and social support is the First Line Leaders (FLL) program, recently designated by ARNG for nation-wide dissemination. The program is centered on enhancing the relationship between junior enlisted soldiers (JES) and their assigned non-commissioned officer (NCO). The Investigators propose to study an augmented FLL program that includes templated guides developed in collaboration with Idaho ARNG stakeholders. The guides, referred to as TAP (Total Health Action Plan), were adapted from two empirically based interventions, Crisis Response Planning and Problem-Solving Therapy, and consist of prompts for open communication and effective engagement and guidelines for responding to impending or current behavioral distress. Given their elevated suicide risk, the Idaho ARNG is a crucial setting to develop this upstream intervention. In this study, the Investigators propose to compare the augmented FLL + TAP program to FLL only, and training as usual (n= 50 NCOs and 100 JES per group) with quarterly assessments for up to one year. The Investigators will examine a random selection of deidentified counseling templates to examine the type and frequency of counseling sessions involving acute crisis and behavioral health difficulties, and online ratings from a random selection of JES using validated instruments to assess upstream indicators of behavioral distress and suicide risk and resilience. The Investigators will also conduct qualitative interviews with a random selection of 20% of the NCOs (n = 30) and JES (n = 60) enrolled in the project to provide personalized pe

Trial Details

FieldValue
Enrollment Target 450 participants
Start Date 2026-06-15
Est. Completion 2028-05-01
Phase NA

Sponsor

University of Rochester

636 total trials

What the Registry Record Tells You About NCT07032636

The ClinicalTrials.gov registry entry for NCT07032636 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 450 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT07032636 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07032636 about?

NCT07032636 is a clinical study titled "Reducing Crises and Suicide Within the Idaho Army National Guard". Military suicide is an ongoing public health concern, particularly within the Army National Guard (ARNG), with longstanding effects on fellow soldiers, family, and friends. The straddling of military and civilian worlds for ARNG can worsen risk factors for suicide, including increased social isolati...

What is the current status of trial NCT07032636?

This trial is currently recruiting. It is a NA study. The enrollment target is 450 participants. The study started on 2026-06-15. Estimated completion is 2028-05-01.

Who is sponsoring clinical trial NCT07032636?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.